NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

GemVax&KAEL Co.Ltd (KQ: 082270)

 
082270 Technical Analysis
5
As on 16th Sep 2025 082270 STOCK Price closed @ 49050.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 14574.68 & Strong Buy for SHORT-TERM with Stoploss of 11545.82 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

082270STOCK Price

Open 49000.00 Change Price %
High 50800.00 1 Day 50.00 0.10
Low 47400.00 1 Week 2750.00 5.94
Close 49050.00 1 Month -6750.00 -12.10
Volume 280241 1 Year 36780.00 299.76
52 Week High 69800.00 | 52 Week Low 9900.00
 
KQ Korea Most Active Stocks
032980 302.00 16.15%
207760 2105.00 29.70%
008040 1397.00 2.72%
008040 1397.00 2.72%
900110 77.00 -8.33%
006910 4490.00 7.93%
044480 585.00 15.84%
085310 1592.00 6.06%
085310 1592.00 6.06%
044180 842.00 8.37%
 
KQ Korea Top Gainers Stocks
115610 1069.00 29.89%
071460 613.00 29.87%
207760 2105.00 29.70%
096040 271.00 29.67%
258830 412.00 26.77%
286750 2130.00 22.70%
093230 1392.00 20.52%
093230 1392.00 20.52%
024810 899.00 16.75%
134580 2920.00 16.57%
 
KQ Korea Top Losers Stocks
318020 4195.00 -76.82%
097780 874.00 -74.18%
001529 2095.00 -73.81%
001529 2095.00 -73.81%
009275 1800.00 -64.50%
009275 1800.00 -64.50%
091970 604.00 -62.48%
032860 1800.00 -50.55%
016385 10450.00 -37.05%
016385 10450.00 -37.05%
 
 
082270
Daily Charts
082270
Intraday Charts
Whats New @
Bazaartrend
082270
Free Analysis
 
082270 Important Levels Intraday
RESISTANCE55601.80
RESISTANCE53500.60
RESISTANCE52201.80
RESISTANCE50903.00
SUPPORT47197.00
SUPPORT45898.20
SUPPORT44599.40
SUPPORT42498.20
 
082270 Forecast September 2025
4th UP Forecast51632.2
3rd UP Forecast50804.1
2nd UP Forecast50292.2
1st UP Forecast49780.3
1st DOWN Forecast48319.7
2nd DOWN Forecast47807.8
3rd DOWN Forecast47295.9
4th DOWN Forecast46467.8
 
082270 Weekly Forecast
4th UP Forecast50668.68
3rd UP Forecast50149.56
2nd UP Forecast49828.68
1st UP Forecast49507.80
1st DOWN Forecast48592.20
2nd DOWN Forecast48271.32
3rd DOWN Forecast47950.44
4th DOWN Forecast47431.32
 
082270 Forecast2025
4th UP Forecast171684
3rd UP Forecast132355
2nd UP Forecast108044
1st UP Forecast83733.8
1st DOWN Forecast14366.2
2nd DOWN Forecast-9944.28
3rd DOWN Forecast-34254.8
4th DOWN Forecast-73584.3
 
GemVax&KAEL Co.Ltd ( KQ Korea Symbol : 082270 )
Sector : N/A And Other Stocks in Same Sector
 
082270 Other Details
Segment EQ
Market Capital 679555432448.00
Sector
Industry
Offical website >
 
082270 Address
082270
 
082270 Latest News
 
Your Comments and Response on GemVax&KAEL Co.Ltd
 
082270 Business Profile
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution prevention; and pressure facility for preventing equipment erosion within a substation; and 5aver, a fire evacuation mask. It also engages in the research and development of anti-cancer immunotherapeutic and peptide drugs; and provides RIAVAX, an immunotherapeutic peptide for the treatment of locally advanced or metastatic pancreatic cancer. The company was founded in 1998 and is headquartered in Daejeon, South Korea. Address: 58 Techno 11-ro, Daejeon, South Korea
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service